Matches in SemOpenAlex for { <https://semopenalex.org/work/W60463764> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W60463764 endingPage "49" @default.
- W60463764 startingPage "233" @default.
- W60463764 abstract "The prevalence of the behavioral and psychological symptoms of dementia (BPSD) varies between 20-90%, depending on the care settings and severity of the dementia syndrome. BPSD is the major reason for referrals to secondary care. It exacerbates the dementia-associated morbidity and mortality rates. Furthermore, while BPSD is not a properly defined syndrome, it frequently induces psychic and somatic complaints in caregivers. The social and economic impacts of the BPSD far outweigh the importance of the cognitive symptoms of dementia. The aim of this review is to present the most recent findings regarding the recognition, differential diagnosis, aetiology, and pathomechanism of BPSD with a special focus on the local therapeutic possibilities with the atypical antipsychotics. Of utmost importance is the process of identifying the complex bio-psycho-social aetiological factors in parallel with defining the treatment strategies. Only after the correct recognition of the potential aetiology, non-pharmacological interventions are recommended to start with as first choice treatment in mild and mild-to-moderate BPSD, while in moderate and severe cases pharmacotherapeutic approaches are recommended from the start. Recent findings of neuropathological, neurochemical and neuroimaging studies yielded unequivocal evidence that the BPSD symptoms are not a consequence of a single neurotransmitter imbalance, but rather of disproportionate level changes in biogenic amines, excitatory and inhibitory transmitters in the central nervous system. Consequently, the available pharmacotherapy should target the balancing of the dopaminergic, serotoninergic, noradrenergic, excitatory and GABAergic neurotransmission by using antipsychotics, antidepressants, phase-prophylactic agents, and benzodiazepines. Several clinical studies have proven the efficacy of atypical antipsychotics that target multiple neurotransmitter systems in treating BPSD. The first results of the CATIE-AD study also confirm these findings and indicate that the atypical antipsychotics are effective in controlling anger, aggression and delusions in Alzheimer's disease, while cognitive symptoms, quality of life and care needs are not improved." @default.
- W60463764 created "2016-06-24" @default.
- W60463764 creator A5005034134 @default.
- W60463764 creator A5080320221 @default.
- W60463764 creator A5085319910 @default.
- W60463764 date "2008-10-01" @default.
- W60463764 modified "2023-09-23" @default.
- W60463764 title "[Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study]." @default.
- W60463764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19213202" @default.
- W60463764 hasPublicationYear "2008" @default.
- W60463764 type Work @default.
- W60463764 sameAs 60463764 @default.
- W60463764 citedByCount "3" @default.
- W60463764 countsByYear W604637642014 @default.
- W60463764 countsByYear W604637642019 @default.
- W60463764 crossrefType "journal-article" @default.
- W60463764 hasAuthorship W60463764A5005034134 @default.
- W60463764 hasAuthorship W60463764A5080320221 @default.
- W60463764 hasAuthorship W60463764A5085319910 @default.
- W60463764 hasConcept C118552586 @default.
- W60463764 hasConcept C126322002 @default.
- W60463764 hasConcept C137627325 @default.
- W60463764 hasConcept C15744967 @default.
- W60463764 hasConcept C169760540 @default.
- W60463764 hasConcept C170493617 @default.
- W60463764 hasConcept C25876315 @default.
- W60463764 hasConcept C2775864247 @default.
- W60463764 hasConcept C2779134260 @default.
- W60463764 hasConcept C2779483572 @default.
- W60463764 hasConcept C37000724 @default.
- W60463764 hasConcept C70410870 @default.
- W60463764 hasConcept C71924100 @default.
- W60463764 hasConceptScore W60463764C118552586 @default.
- W60463764 hasConceptScore W60463764C126322002 @default.
- W60463764 hasConceptScore W60463764C137627325 @default.
- W60463764 hasConceptScore W60463764C15744967 @default.
- W60463764 hasConceptScore W60463764C169760540 @default.
- W60463764 hasConceptScore W60463764C170493617 @default.
- W60463764 hasConceptScore W60463764C25876315 @default.
- W60463764 hasConceptScore W60463764C2775864247 @default.
- W60463764 hasConceptScore W60463764C2779134260 @default.
- W60463764 hasConceptScore W60463764C2779483572 @default.
- W60463764 hasConceptScore W60463764C37000724 @default.
- W60463764 hasConceptScore W60463764C70410870 @default.
- W60463764 hasConceptScore W60463764C71924100 @default.
- W60463764 hasIssue "4" @default.
- W60463764 hasLocation W604637641 @default.
- W60463764 hasOpenAccess W60463764 @default.
- W60463764 hasPrimaryLocation W604637641 @default.
- W60463764 hasRelatedWork W1564132981 @default.
- W60463764 hasRelatedWork W1994220216 @default.
- W60463764 hasRelatedWork W199823957 @default.
- W60463764 hasRelatedWork W2009815181 @default.
- W60463764 hasRelatedWork W2118738821 @default.
- W60463764 hasRelatedWork W2141634534 @default.
- W60463764 hasRelatedWork W2395979459 @default.
- W60463764 hasRelatedWork W3138672441 @default.
- W60463764 hasRelatedWork W4241327740 @default.
- W60463764 hasRelatedWork W984801916 @default.
- W60463764 hasVolume "10" @default.
- W60463764 isParatext "false" @default.
- W60463764 isRetracted "false" @default.
- W60463764 magId "60463764" @default.
- W60463764 workType "article" @default.